Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ormat Technologies | ORA | 28. mar 2025 | 70.57 | +0.66 |
Orrstown Financial Services | ORRF | 28. mar 2025 | 30.00 | -1.67 |
Orthofix Medical | OFIX | 28. mar 2025 | 16.06 | -0.62 |
OrthoPediatrics | KIDS | 28. mar 2025 | 24.74 | -0.04 |
Oruka Therapeutics | ORKA | 28. mar 2025 | 12.50 | +4.60 |
OS Therapies | OSTX | 28. mar 2025 | 1.62 | 0.00 |
Oscar Health A | OSCR | 28. mar 2025 | 13.30 | -1.34 |
Oshkosh | OSK | 28. mar 2025 | 94.31 | -2.83 |
OSI Systems | OSIS | 28. mar 2025 | 193.32 | -2.91 |
Osisko Development | ODV | 28. mar 2025 | 1.49 | -0.67 |
Osisko Gold Royalties | OR | 28. mar 2025 | 20.92 | -1.13 |
OSR Holdings | OSRH | 28. mar 2025 | 2.40 | 0.00 |
Ostin Technology Group | OST | 28. mar 2025 | 1.73 | +2.37 |
Otis Worldwide | OTIS | 28. mar 2025 | 102.11 | -0.87 |
Otter Tail | OTTR | 28. mar 2025 | 80.73 | +0.22 |
Ouster | OUST | 28. mar 2025 | 9.54 | -4.41 |
Outbrain | OB | 28. mar 2025 | 3.80 | -3.55 |
Outfront Media | OUT | 28. mar 2025 | 16.28 | -0.67 |
Outlook Therapeutics | OTLK | 28. mar 2025 | 1.32 | -5.71 |
Outset Medical | OM | 28. mar 2025 | 12.58 | +3.88 |
Ovid Therapeutics | OVID | 28. mar 2025 | 0.35 | -7.63 |
Ovintiv | OVV | 28. mar 2025 | 42.22 | -2.54 |
Owens & Minor | OMI | 28. mar 2025 | 8.58 | +0.94 |
Owens Corning | OC | 28. mar 2025 | 142.63 | -3.07 |
Owlet A | OWLT | 28. mar 2025 | 3.58 | -10.50 |
Oxbridge Re | OXBR | 28. mar 2025 | 2.02 | +1.51 |
Oxford Industries | OXM | 28. mar 2025 | 58.96 | -5.72 |
Oxford Lane Capital | OXLC | 28. mar 2025 | 4.65 | -0.21 |
Oxford Lane Capital 2027 Pref | OXLCP | 28. mar 2025 | 24.18 | -0.09 |
Oxford Square Capital | OXSQ | 28. mar 2025 | 2.56 | -0.39 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.